| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $616.3M | +87.3% |
| Cost of Revenue | $100.7M | +161.7% |
| R&D Expense | $160.2M | +69.9% |
| SG&A Expense | $232.0M | +50.4% |
| Operating Income | $123.3M | +194.1% |
| Pre-tax Income | $107.4M | +319.6% |
| Income Tax | -$339.8M | — |
| Net Income | $447.2M | +1812.4% |
| EPS (Basic) | $3.10 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.1M | -56.0% |
| Short-term Investments | $62.8M | -52.1% |
| Accounts Receivable | $305.6M | +136.6% |
| Inventory | $125.6M | +13.7% |
| Current Assets | $630.8M | +11.4% |
| Total Assets | $1.06B | +84.1% |
| Current Liabilities | $153.8M | +69.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.8M | +38.9% |
| Capital Expenditures | $214K | +375.6% |
| Investing Cash Flow | $13.8M | +1431.9% |
| Financing Cash Flow | -$89.7M | -169.8% |
| Free Cash Flow | -$25.0M | +38.4% |
| +1837.5% |
| EPS (Diluted) | $2.77 | +1746.7% |
| Long-term Debt |
| $245.6M |
| +0.5% |
| Total Liabilities | $415.2M | +16.9% |
| Stockholders' Equity | $648.0M | +191.4% |